CRISPR/Cas9 Lentivirus Production Service at Creative Biogene

In the ever-evolving field of genome editing, the CRISPR/Cas9 technology has emerged as a groundbreaking approach for precise genetic alterations. This innovative system utilizes a chimeric single guide RNA (sgRNA) to direct the Cas9 protein towards specific DNA sequences, allowing for targeted modifications in the genome. With the option to simultaneously target various genomic loci, the CRISPR/Cas9 system is uniquely designed for multiplex gene editing, making it an invaluable tool for both research and therapeutic applications.

Overview of the QVirus™ Platform

Creative Biogene has developed the QVirus™ Platform to streamline the production of lentiviral CRISPR/Cas9 constructs. This platform enables rapid generation of constructs that facilitate multiplex gene manipulation, thereby enhancing the efficiency of genomic editing experiments in challenging cell types, including primary cells and progenitor cells.

Utilizing the lentiviral system provides several advantages, such as stable expression of the sgRNA and Cas9, which can be maintained in both dividing and non-dividing cells. Researchers can achieve complete knockout of target genes in their cell lines, promoting deeper insights into gene function and disease modeling.

Service Offerings

Creative Biogene offers two distinct systems tailored to meet the specific needs of researchers:

Single-Vector CRISPR-Cas9 System

This system features both sgRNA and Cas9 expressed within a single lentiviral vector. Key benefits include:

• Elimination of co-transduction steps, simplifying the workflow.
• Integration into the host cell genome, ensuring that the sequence is inherited through cell divisions.
• Stability that allows cells to be treated and maintained over multiple passages without loss of the lentiviral construct.

Two-Vector CRISPR-Cas9 System

The two-vector approach involves pre-transduction with a Cas9 lentivirus, helping to reduce background noise in knockout screens. Attributes include:

• Delivery of high-titer sgRNA lentivirus for efficient transduction.
• Option for tet-inducible or constitutive expression of U6 promoters.
• Easy selection due to differing antibiotic resistance markers in the vectors.

Why Choose Creative Biogene?

The advantages of using the QVirus™ Platform are clear:

• Efficient delivery of Cas9, facilitating precise and multipoint gene editing.
• Reduction of tedious procedures related to cloning and vector construction.
• High yields of lentivirus ensure robust genetic manipulation capabilities, regardless of the cell type.

Creative Biogene welcomes inquiries related to custom requirements, ensuring that researchers’ specific needs are met with expertise and support.

Conclusion

The CRISPR/Cas9 Lentivirus Production Service at Creative Biogene stands at the forefront of genetic research, empowering scientists to explore the complexities of gene function and disease. By leveraging advanced technologies and offering tailored solutions, Creative Biogene positions itself as a reliable partner in the realm of genomic engineering.